Literature DB >> 9439675

Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary.

A Sakurada1, A Suzuki, M Sato, H Yamakawa, K Orikasa, S Uyeno, T Ono, N Ohuchi, S Fujimura, A Horii.   

Abstract

In the present study, we searched for genetic alterations of the entire coding region of PTEN/MMAC1, a recently isolated candidate tumor suppressor gene, in 178 specimens from Japanese patients with various malignant tumors by the polymerase chain reaction-single strand conformation polymorphism method. The samples consisted of 11 glioblastoma multiformes (GBMs), 14 astrocytomas, 47 breast cancers, 25 non-small cell lung cancers, 9 small cell lung cancers, 8 pancreatic cancers, 24 renal cell carcinomas, 20 ovarian cancers, and 20 metastatic lung tumors from various organs. Only one somatic frameshift mutation at codon 319 was observed in one (9%) of eleven GBMs. Our results suggest that mutation of the PTEN/MMAC1 gene does not play a major role in carcinogenesis, at least in the tumor types from Japanese patients analyzed in this study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439675      PMCID: PMC5921310          DOI: 10.1111/j.1349-7006.1997.tb00324.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


glioblastoma multiforme mutated in multiple advanced cancers 1 phosphatase and tensin homolog deleted on chromosome ten polymerase chain reaction single strand conformation polymorphism loss of heterozygosity
  11 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus.

Authors:  T Mayama; T Mori; K Abe; H Sasano; T Nishihira; S Satomi; A Horii
Journal:  Eur J Surg Oncol       Date:  1997-08       Impact factor: 4.424

3.  Dideoxy sequencing method using denatured plasmid templates.

Authors:  M Hattori; Y Sakaki
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

4.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

5.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

6.  Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan.

Authors:  J Kuratsu; Y Ushio
Journal:  J Neurosurg       Date:  1996-06       Impact factor: 5.115

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Epidemiology of brain tumors: the national survey of intracranial neoplasms.

Authors:  A E Walker; M Robins; F D Weinfeld
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

Review 10.  A tiger behind many doors: multiple genetic pathways to malignant glioma.

Authors:  D N Louis; J F Gusella
Journal:  Trends Genet       Date:  1995-10       Impact factor: 11.639

View more
  30 in total

1.  Polymorphisms in PTEN in breast cancer families.

Authors:  B T Carroll; F J Couch; T R Rebbeck; B L Weber
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

2.  Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.

Authors:  Chunlan Sun; Takashi Yamato; Emiko Kondo; Toru Furukawa; Hidetoshi Ikeda; Akira Horii
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

3.  Integrative survival-based molecular profiling of human pancreatic cancer.

Authors:  Timothy R Donahue; Linh M Tran; Reginald Hill; Yunfeng Li; Anne Kovochich; Joseph H Calvopina; Sanjeet G Patel; Nanping Wu; Antreas Hindoyan; James J Farrell; Xinmin Li; David W Dawson; Hong Wu
Journal:  Clin Cancer Res       Date:  2012-01-18       Impact factor: 12.531

4.  Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.

Authors:  Y C Hu; K Y Lam; J C Tang; G Srivastava
Journal:  Mol Pathol       Date:  1999-12

5.  Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.

Authors:  Harika Sabbineni; Abdulrahman Alwhaibi; Anna Goc; Fei Gao; Alanna Pruitt; Payaningal R Somanath
Journal:  Eur J Pharmacol       Date:  2015-07-03       Impact factor: 4.432

Review 6.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

7.  Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.

Authors:  Kiran Mahajan; Domenico Coppola; Sridevi Challa; Bin Fang; Y Ann Chen; Weiwei Zhu; Alexis S Lopez; John Koomen; Robert W Engelman; Charlene Rivera; Rebecca S Muraoka-Cook; Jin Q Cheng; Ernst Schönbrunn; Said M Sebti; H Shelton Earp; Nupam P Mahajan
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

8.  TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.

Authors:  Jimmy Y C Chow; Makiko Ban; Helen L Wu; Flang Nguyen; Mei Huang; Heekyung Chung; Hui Dong; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-25       Impact factor: 4.052

9.  Germline PTEN mutations in Cowden syndrome-like families.

Authors:  D J Marsh; P L Dahia; S Caron; J B Kum; I M Frayling; I P Tomlinson; K S Hughes; R A Eeles; S V Hodgson; V A Murday; R Houlston; C Eng
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

10.  TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells.

Authors:  Jimmy Y C Chow; Hui Dong; Khai T Quach; Phuoc Nam Van Nguyen; Kevin Chen; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-31       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.